Clinical Trial Update: Efficacy and Safety of NM-702 Tablets for the Treatment of Intermittent Claudication [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy and safety of NM-702 tablets for intermittent claudication; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication
• Peripheral Vascular Disease

Drugs mentioned

• NM-702 (NM-702)

Snippet

Sponsor: Nissan Chemical Industries | Conditions: Intermittent Claudication, Peripheral Vascular Disease | Phase 2 | Status: COMPLETED